Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen mannitol injection for postoperative rehabilitation after gastrointestinal tumor surgery
ChiCTR2300076213Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acetaminophen + mannitol in gastric cancer (GC), colorectal cancer (CRC) and gastrointestinal stromal tumor (GIST) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Ramsay sedation score, Serum IL-6 and 5 more. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
acetaminophen + mannitol
03
Conditions
gastric cancer (GC)colorectal cancer (CRC)gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR2300076213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076213.